Brief: Bausch Can Block Alvogen From Copying Xifaxan Diarrhea Drug Until 2029-Us Appeals Court
April 11 (Reuters) - Bausch Health Companies Inc
BHC.TO :
* BAUSCH CAN BLOCK ALVOGEN FROM COPYING XIFAXAN DIARRHEA
DRUG
UNTIL 2029-US APPEALS COURT
Further company coverage: BHC.TO
(Reporting By Caroline Humer)
((caroline.humer@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsCanada Stocks: TSX inches lower as tech and mining shares fall
Bausch Health Companies Inc. reports results for the quarter ended September 30 - Earnings Summary
Brief: Bausch Health Announces Full Redemption Of 8.500% Senior Notes Due 2027
Brief: Bausch Health Announces $50 Million Share Repurchase Program
Brief: Bausch Health Announces $50 Million Share Repurchase Program